tradingkey.logo
搜尋

Artivion Inc

AORT
添加自選
23.869USD
+0.319+1.35%
收盤 07/02, 13:00美東報價延遲15分鐘
1.16B總市值
93.02本益比TTM

Artivion Inc

23.869
+0.319+1.35%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.35%

5天

+8.35%

1月

+13.39%

6月

-47.67%

今年開始到現在

-47.67%

1年

-22.38%

關鍵數據
23.640今開
24.150最高
498.13K成交量
93.02本益比TTM
50.73本益比動
--股利TTM
1.03%換手率
23.550昨收
23.310最低
7.71M成交額
虧損本益比靜
2.57市淨率
0.00%股息率 TTM
1.40%ROA
48.25052週最高
0.70量比
-13.34M淨利潤
48.50M總股本
0.2566每股盈餘TTM
1.29Beta
3.14%ROE
19.16052週最低
3.57%振幅
64.85%毛利率
1.16B總市值
6.92回報/風險
2.21%風險率

TradingKey Artivion Inc股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Artivion Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名17/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為42.00。中期看,股價處於下降通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Artivion Inc評分

相關信息

行業排名
17 / 204
全市場排名
70 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Artivion Inc亮點

亮點風險
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
業績高增長
公司營業收入穩步增長,連續3年增長24.67%
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值91.78,處於3年歷史高位
機構加倉
最新機構持股45.29M股,環比增加1.10%
查克·羅伊斯持倉
明星投資者查克·羅伊斯持倉,最新持倉684.09K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.13

分析師目標

基於 8 分析師
買入
評級
42.000
目標均價
+86.92%
漲幅空間

Artivion Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Artivion Inc簡介

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
公司代碼AORT
公司Artivion Inc
CEOMackin (James Patrick)
網址https://artivion.com/

常見問題

Artivion Inc(AORT)的當前股價是多少?

Artivion Inc(AORT)的當前股價是 23.55。

Artivion Inc 的股票代碼是什麼?

Artivion Inc的股票代碼是AORT。

Artivion Inc股票的52週最高點是多少?

Artivion Inc股票的52週最高點是48.25。

Artivion Inc股票的52週最低點是多少?

Artivion Inc股票的52週最低點是19.16。

Artivion Inc的市值是多少?

Artivion Inc的市值是1.14B。

現在Artivion Inc(AORT)的股票是買入、持有還是賣出?

根據分析師評級,Artivion Inc(AORT)的總體評級為買入,目標價格為42.00。

Artivion Inc(AORT)股票的每股收益(EPS TTM)是多少

Artivion Inc(AORT)股票的每股收益(EPS TTM)是0.22。